Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations

Open Forum Infectious Diseases
Fernanda C LessaScott K Fridkin

Abstract

Clostridium difficile infection (CDI) is no longer restricted to hospital settings, and population-based incidence measures are needed. Understanding the determinants of CDI incidence will allow for more meaningful comparisons of rates and accurate national estimates. Data from active population- and laboratory-based CDI surveillance in 7 US states were used to identify CDI cases (ie, residents with positive C difficile stool specimen without a positive test in the prior 8 weeks). Cases were classified as community-associated (CA) if stool was collected as outpatients or ≤3 days of admission and no overnight healthcare facility stay in the past 12 weeks; otherwise, cases were classified as healthcare-associated (HA). Two regression models, one for CA-CDI and another for HA-CDI, were built to evaluate predictors of high CDI incidence. Site-specific incidence was adjusted based on the regression models. Of 10 062 cases identified, 32% were CA. Crude incidence varied by geographic area; CA-CDI ranged from 28.2 to 79.1/100 000 and HA-CDI ranged from 45.7 to 155.9/100 000. Independent predictors of higher CA-CDI incidence were older age, white race, female gender, and nucleic acid amplification test (NAAT) use. For HA-CDI, older age...Continue Reading

References

Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R FeketyM E Mulligan
Sep 1, 1997·Clinical Immunology and Immunopathology·D L JacobsonN M Graham
Dec 2, 1999·Immunologic Research·L GinaldiD Quaglino
May 8, 2000·Social Science & Medicine·M T FrenchC B McCoy
May 18, 2006·Emerging Infectious Diseases·L Clifford McDonaldDaniel B Jernigan
Feb 7, 2008·Emerging Infectious Diseases·Matthew D RedelingsLaurene Mascola
Apr 4, 2008·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Apr 9, 2008·Emerging Infectious Diseases·Florian BurckhardtTim Eckmanns
Apr 25, 2008·The Journal of Antimicrobial Chemotherapy·M H WilcoxW N Fawley
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Denise GravelUNKNOWN Canadian Nosocomial Infection Surveillance Program
May 8, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Robert J CampbellL Clifford McDonald
Sep 8, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Pascal J LambertGreg W Hammond
Mar 24, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stuart H CohenUNKNOWN Infectious Diseases Society of America
Mar 31, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer L KuntzPhilip M Polgreen
Nov 26, 2010·Archives of Internal Medicine·Jeffrey T KullgrenTracy A Lieu
Jun 10, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vanessa StevensEdwin van Wijngaarden
Aug 11, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kimberlee S FongThomas G Fraser
Nov 4, 2011·The New England Journal of Medicine·Vivian G LooAndre Dascal
Apr 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Aron J HallBen A Lopman
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erik R Dubberke, Margaret A Olsen
Oct 9, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Deepa PawarGhinwa Dumyati
Apr 12, 2013·The New England Journal of Medicine·Lauri A HicksRobert J Hunkler
Jun 20, 2013·JAMA Internal Medicine·Amit S ChitnisFernanda C Lessa
Jun 22, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen M BrecherElisabeth Nagy
Aug 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carolyn V GouldUNKNOWN Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention
Sep 11, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Rebekah W MoehringDeverick J Anderson

❮ Previous
Next ❯

Citations

Aug 21, 2015·Emerging Infectious Diseases·Shelley S MagillScott K Fridkin
Jan 15, 2015·Infectious Disease Clinics of North America·Dale N Gerding, Fernanda C Lessa
Aug 4, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Warren N FawleyUNKNOWN Clostridium difficile Ribotyping Network (CDRN) Working Group
Mar 20, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sara L Revolinski, L Silvia Munoz-Price
Nov 8, 2017·Current Infectious Disease Reports·Jason A Clayton, Philip Toltzis
Jan 4, 2019·Journal of Global Health·Evelyn BalsellsHarish Nair
Apr 4, 2020·The New England Journal of Medicine·Alice Y GuhUNKNOWN Emerging Infections Program Clostridioides difficile Infection Working Group
Nov 27, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mariam YounasMajdi N Al-Hasan

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Antimicrobial Chemotherapy
Abhishek DeshpandeCurtis J Donskey
The New England Journal of Medicine
Fernanda C LessaL Clifford McDonald
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Carolyn V GouldClostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention
© 2022 Meta ULC. All rights reserved